ClinicalTrials.Veeva

Menu

The Effect of Cold Storage Solutions on Ischemic Injury in Lung Transplantation

Johns Hopkins University logo

Johns Hopkins University

Status and phase

Completed
Phase 3

Conditions

Lung Transplant Recipients

Treatments

Device: Celsior Cold Storage Solution

Study type

Interventional

Funder types

Other

Identifiers

NCT00284726
00-10-25-03

Details and patient eligibility

About

The purpose of this study is to compare 2 different cold storage solutions, used to preserve donor lungs for lung transplantation, and their effect on cytokine activation related to ischemic reperfusion injury. Primary endpoint is 30 day survival.

Full description

The length of ischemic time in harvesting lung allografts is associated with graft survival. It is further thought that ischemic changes in early post-transplantation bronchoscopic biopsies has a direct correlation with later development of chronic rejection.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Any patient undergoing a lung trasnplant at Johns Hopkins Hospital -

Exclusion criteria

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems